Colonic carcinoma (CC) is a highly prevalent cancer in the Netherlands, with almost 9000 new cases annually
1. Adjuvant chemotherapy is recommended for patients with lymph node metastases (stage 3 disease) to improve survival
2. A significant proportion of patients with stage 3 CC do not start chemotherapy in time or require treatment adaptions owing to toxicity
3,4, with worrisome decreased survival rates as a result.